China National Biotec Group will have the capacity to produce 1 billion doses of Covid-19 vaccines next year, said the president of the group, Chinanews reported. CNBG, a unit of state-owned pharmaceutical giant China National Pharmaceutical Group (Sinopharm), has been recognized as a comprehensive biopharmaceutical enterprise focusing on human vaccines, blood products, medical aesthetics and animal healthcare.